§ Federal grant opportunity · RFA-RM-27-002
NIH Director’s New Innovator Award (DP2 Clinical Trial Optional)
National Institutes of Health is accepting applications for NIH Director’s New Innovator Award (DP2 Clinical Trial Optional). The deadline is August 17, 2026 and the published award range is $475K.
Key facts
- Funder
- National Institutes of Health
- Application deadline
- August 17, 2026
- Award range
- $475K
- Eligibility
- Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
- Geography
- United States
- Focus areas
- Health
- Opportunity number
- RFA-RM-27-002
Program overview
The NIH Director"s New Innovator Award supports early-stage investigators of exceptional creativity who propose bold and highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the mission of NIH. Applications in any area within the biomedical sciences are welcome; topics may involve basic, translational, or clinical research. The NIH Director's New Innovator Award complements other ongoing efforts by NIH and its Institutes and Centers to fund early-stage investigators. The NIH Director"s New Innovator Award is a component of the High-Risk, High-Reward Research (HRHR) program of the NIH Common Fund.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from National Institutes of Health.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before August 17, 2026, allowing time for registration and validation.
Related grant opportunities
- DoW Epilepsy Virtual Post-Traumatic Epilepsy Research Center – Faculty Award
- Fiscal Year 2026 Cooperating Technical Partners (CTP) Program - Region 4
- DoW Epilepsy Leveraging Research Award
- DoW Epilepsy Research Partnership Award
- Fiscal Year 2026 Cooperating Technical Partners (CTP) Program - Region 3
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.